Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC reduced its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 1.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 57,582 shares of the company’s stock after selling 791 shares during the period. Janney Montgomery Scott LLC’s holdings in Privia Health Group were worth $1,049,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of PRVA. Allspring Global Investments Holdings LLC raised its position in shares of Privia Health Group by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock worth $176,000 after purchasing an additional 756 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its holdings in Privia Health Group by 15.9% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 25,378 shares of the company’s stock valued at $497,000 after acquiring an additional 3,487 shares during the last quarter. Quantbot Technologies LP acquired a new position in Privia Health Group in the 1st quarter valued at $196,000. SG Americas Securities LLC acquired a new position in Privia Health Group in the 1st quarter valued at $131,000. Finally, Swiss National Bank raised its holdings in Privia Health Group by 0.8% in the 1st quarter. Swiss National Bank now owns 186,400 shares of the company’s stock valued at $3,652,000 after acquiring an additional 1,400 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $21.20 on Friday. The firm has a 50-day moving average of $18.71 and a two-hundred day moving average of $18.49. The stock has a market cap of $2.54 billion, a P/E ratio of 212.00, a PEG ratio of 5.07 and a beta of 0.76. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $24.30.

Insider Buying and Selling at Privia Health Group

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the transaction, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This represents a 35.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 14.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on PRVA. Robert W. Baird boosted their price target on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. Barclays boosted their price target on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, November 8th. Truist Financial upped their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Royal Bank of Canada restated an “outperform” rating and set a $28.00 price objective on shares of Privia Health Group in a report on Wednesday, August 14th. Finally, KeyCorp started coverage on Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective for the company. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $25.07.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.